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Abstract
Aims: To measure maternal serum interleukins (IL) in
pregnancy, delivery and early puerperium, and to identify
their potential determinants.
Methods: Prospective longitudinal measures of serum
IL-1b, IL-6 and IL-8 in 38 healthy pregnant women at
antenatal visits, through labor and delivery, with clinical
correlates (infection, vaginal hemorrhage and anemia)
recorded by questionnaire.
Results: Pregnancy IL levels remained consistently low.
IL-1b increased shortly before delivery, then returned to
pregnant levels, except where blood loss exceeded
500 ml. IL-6 and IL-8 rose at labor onset and exceeded
pregnancy levels through postpartum day three. Post-
partum IL-6 was higher after non-elective cesarean sec-
tion than after spontaneous delivery (P-0.0001), and
where blood loss exceeded 500 ml. IL-6 and IL-8 were
higher with systemic infection during delivery (P-0.0001)
and on postpartum day one (P-0.05); IL-8 was higher in
anemia (delivery: P-0.005; postpartum day 1: P-0.05).
Differences due to delivery mode and systemic infection
remained significant after correction for other conditions.
Conclusions: Labor-dependent inflammation increases
all IL levels at delivery. Further studies with larger sample
sizes are required to establish reference values differen-
tiating physiology from pathology as an aid to peripartum
management.
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Introduction
The inflammatory cytokines, interleukins-1b (IL-1b), IL-6
and IL-8, help to maintain the trophoblast in early preg-
nancy. They also play a major role in intrauterine infec-
tion, especially after premature rupture of membranes,
and in preterm and term labor irrespective of infection
w23, 25x. IL-1b has been proposed as the master cyto-
kine of the inflammatory response w7x, capable of induc-
ing IL-6 and IL-8, among other cytokines. IL-8 is a
chemotactic cytokine involved in rupture of the mem-
branes and cervical ripening w14x; together with IL-6, it
plays an important role in preterm cervical remodeling w6,
25x.
Although cytokines generally have paracrine and auto-
crine effects, they can also act remotely. Thus their pres-
ence in peripheral venous blood may reflect remote
disease (e.g. candidiasis w21x, and acute sepsis w11x).
Previous studies in pregnancy have looked at amniotic
fluid and/or tissues directly involved in parturition (cervix,
amnion, chorion, placenta, lower uterine segment, and
vagina) w9, 22x. Serum IL-1b, IL-6 and IL-8 appear to play
a major role during pregnancy w5, 10, 15, 27x, towards
term and at delivery w3, 16, 28x, notably with increased
levels in labor w10, 13, 14x.
In suspected amniotic fluid infection syndrome, the
benefit of measuring inflammatory IL levels using an inva-
sive procedure (amniocentesis) — with the risk of induc-
ing premature contractions and/or premature rupture of
the membranes — has to be weighed against treating
the patient solely on the basis of clinical findings and
non-invasive investigations. As yet, while there is a ref-
erence profile for maternal serum IL-6 throughout preg-
nancy, there is none for IL-1b or IL-8 w28x. There are no
longitudinal cytokine profiles encompassing labor and
the early puerperium; current values are at best trimes-
trial. Such studies have found no causal relationship
between cytokine levels and events during pregnancy
and delivery.
The aims of this study were therefore to establish
longitudinal reference cytokine profiles through pregnan-
cy and peripartum and to identify their potential
determinants.
Patients and methods
A longitudinal prospective study of inpatients and outpatients of
the Department of Obstetrics, Zurich University Hospital, was
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Table 1 Population demographics (mean"se; ns38).
Age (years) 28.4"0.87
Parity 1.9"0.14
Gravidity 2.4"0.19
Race (patients, n)
Caucasian 22
Asian 12
African 4
Marital status (n)
Married 37
Unmarried 1
Cigarettes)5/day (n) 5
conducted following institutional review board approval. Healthy
women (no chronic or acute infection, degenerative disease and
tumors, or medication other than routine oral iron and vitamin
supplementation during pregnancy) were recruited consecutively
in the first trimester ()8.0F12.0 weeks). Gestational age was
calculated from the first day of the last menstrual period and
first trimester ultrasound; dates were corrected to the ultrasound
data where appropriate. Women giving their written informed
consent were included if the clinical examination was normal. At
the booking visit, history and general status were obtained using
a standardized questionnaire. At subsequent visits, relevant
signs, symptoms, results, diagnoses and treatments were added
to each patient’s file.
The criteria for retrospective exclusion from the final analysis
were non-compliance/withdrawal of consent; multiple pregnan-
cy; and during pregnancy: acute systemic infection (malaria, tox-
oplasmosis), recent vaginal hemorrhage, oligohydramnios,
premature contractions or rupture of the membranes; elective
cesarean section or instrumental vaginal delivery. There were no
other exclusion criteria for delivery or the puerperium.
Blood samples were taken a) during pregnancy either monthly
at the routine outpatient visits or once at the last pregnancy visit
near term ()36.0 weeks), b) during labor, c) at delivery (max.
30 min thereafter) and d) at 1, 2 and 3 days postpartum during
hospitalization.
At each visit a vaginal wet preparation was taken for micros-
copy and the urine was analyzed using Uristix (Bayer Diagnos-
tics MfG, Bridgend, UK). Local vaginal infection was diagnosed
by unusual discharge (typical quality, quantity, color, odor, asso-
ciated symptoms), which was pH-tested, examined for clue
cells, and treated with KOH using Amsel’s criteria for bacterial
vaginosis. The wet preparation was examined for hyphae and/
or spores, and microbiological confirmation sought for typical
mycosis symptoms, mainly Candida. Carriership alone did not
qualify as infection. A urine culture was done routinely at the
booking visit and at least once per trimester, but more often if
indicated. Urinary tract infection was diagnosed by positive urine
nitrite and microbiological culture, with or without clinical symp-
toms. Further diagnostic tests were only performed in cases of
overt clinical infection.
Other information collected included details of contractions
(frequency, amplitude), respiratory and gastrointestinal symp-
toms, and current medication. Delivery blood loss was estimated
using our standard department procedures and the hemoglobin
was checked on postpartum day three. Postpartum hemorrhage
was diagnosed as blood loss G500 ml, and puerperal anemia
as a postpartum Hb F9.5 mg/dl. Standardized placental histol-
ogy was performed in all cases as detailed in a previous study
w10x.
Cytokines
Samples (10-ml) of venous blood were taken into untreated ster-
ile glass tubes and immediately centrifuged on site at 3500 rpm
for 10 min at 48C; 0.5-ml aliquots of the supernatant were imme-
diately frozen in polypropylene tubes at y708C and stored until
assay. There were no freeze-thaw cycles. Commercial enzyme-
linked immunoassays were used according to the manufactu-
rer’s recommendations to measure IL-1b, IL-6, IL-8 (Quantikine
TM, R&D Systems, Minneapolis, MN, USA). All reagents and
samples were brought to room temperature before use. The low-
er limits of detection were 1, 0.7 and 10 pg/ml, corresponding
to log values 0, y0.155 and 1 pg/ml, respectively.
Statistical analysis
Data were sampled prospectively after each outpatient visit and
analyzed in Statview 5.4 (Abacus Concepts, Berkeley, California)
for Windows 6.0. The Kolmogorov-Smirnov test was used to test
for normal distribution of cytokine concentrations, and log trans-
formation was performed if necessary. The paired t-test (log val-
ues) was used to test the mean differences in the same group,
and the unpaired t-test (log values) for mean differences
between the two groups. Analysis of variance (ANOVA) was used
to test the dependence of cytokine levels on several parameters.
A P value -0.5 was considered significant. Values are given as
mean"se.
Results
Subjects
The initial recruitment of 70 women was reduced to 38
in the final analysis due to spontaneous abortion (ns5);
non-compliance/withdrawal of consent (ns6); toxoplas-
mosis seroconversion during pregnancy (ns3); delivery
at-36 weeks (ns2); twin pregnancy, fetal malformation,
severe intrauterine growth retardation, severe vaginal
bleeding, malaria, preeclampsia, instrumental vaginal
delivery (ns1 each) and elective cesarean section (ns9).
Table 1 shows the demographics of the 38 women. Mean
gestational age at delivery was 39.5"1.4 (range:
36.4–41.6) weeks. No woman had premature contrac-
tions; one ruptured her membranes )24 hours before
term delivery. Details of potential obstetric determinants
of cytokine levels are given in Table 2.
Cytokines
For data analysis, blood taken monthly from 26 women
and once near term was available from 12 women, result-
ing in 38 data sets for delivery and the puerperium. Cyto-
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Table 2 Potential obstetric determinants of cytokine levels.
Patients (n)
During pregnancy
Local vaginal infection 9*
Urinary tract infection 9
During delivery/puerperium
Local vaginal infection 10†
Urinary tract infection 4
Non-elective cesarean section 7
Systemic infection 8‡
Postpartum hemorrhage ()500 ml) 6
Postpartum anemia (Hb-9.5 g/dl) 9
* bacterial vaginosis (ns1); mycosis (ns8)
† bacterial vaginosis (ns1); mycosis (ns7); beta-hemolytic
streptococci group B (ns2)
‡ chorioamnionitis (ns4); endomyometritis (ns1); pneumonia
(ns2); urosepsis (ns1)
Figure 2 Log IL-6 concentrations (mean"se) before (A) and
during labor (B), at delivery (C) and 1, 2 and 3 days postpartum
(D–F) in non-elective cesarean section (NECS; ns7) versus
spontaneous vaginal delivery (SVD).
*P-0.0001 NECS versus SVD at intervals D and E.
Figure 1 Antenatal longitudinal log IL-6 concentrations (ns26).
Levels were not increased in women with local vaginal infection
(LVI) and urinary tract infection (UTI) (cross; ns1), local vaginal
infection (closed circle; ns9) and urinary tract infection (triangle;
ns8) versus normal women without any complication during
pregnancy (open circle).
kine values were log normally distributed, and are thus
given as log values.
For pregnancy, antenatal profiles in the 26 women
longitudinally analyzed did not differ significantly
between the beginning (F12.0 weeks) and the end of
pregnancy ()36.0 weeks) in terms of either IL-1b
(0.30"0.12 versus 0.34"0.04 pg/ml) or IL-8 (1.21"0.07
versus 1.15"0.03 pg/ml) (paired t-test). Many IL-1b lev-
els were just above the limit of detection. IL-6 levels were
slightly higher at the end than at the beginning of preg-
nancy (0.52"0.03 versus 0.47"0.03 pg/ml; P-0.05)
(Figure 1). Patients with local vaginal and/or urinary tract
infection had no higher values for all three analyzed cyto-
kines than healthy women without any complication dur-
ing pregnancy.
For peripartum data analysis, the last prelabor values
of the 26 women studied longitudinally plus the single
values of the 12 additional women were used as a base-
line (prelabor). All three cytokines increased significantly
after labor onset (Table 3). Only IL-1b levels fell back to
the prelabor baseline; IL-6 and IL-8 levels remained sig-
nificantly raised through postpartum day three. With
respect to mode of delivery, prelabor IL-6 levels did not
differ, but subsequent peak values were higher in the
cesarean section group, significantly so on postpartum
days one and two (P-0.0001; Figure 2). The changes in
IL-8 and IL-1b followed a similar but less significant pat-
tern (IL-8: postpartum day one versus prelabor: Ps0.03;
IL-1b: NS). Tests of the relationship to potential deter-
minants (Table 2) found no evidence of higher levels peri-
partum in women with versus women without local
vaginal or urinary tract infections. However, all three cyto-
kines were elevated during labor in women with systemic
infections (ns8); IL-6 levels remained significantly higher
at delivery and on postpartum day one, similarly IL-8 until
delivery only (Figure 3). In women with blood loss
)500 ml (ns6), IL-1b and IL-6 levels were higher during
delivery and/or postpartum day one and postpartum day
two (P-0.05; Figure 4). In anemic women (ns9), IL-6
levels followed a parallel course to that in their non-ane-
mic counterparts, although at a non-significant higher
level, while IL-1b levels only differed from prelabor during
delivery (P-0.05); IL-8 levels (Figure 5) were highest at
delivery (P-0.005 versus prelabor) and on postpartum
day one (P-0.05).
Using the ANOVA test, all shown significant cytokine
elevations remained independent of other determinants.
Discussion
Our longitudinal study incorporating detailed multifacet-
ed data collection at every time point, notably with regard
to infection, has shown that the three inflammatory cyto-
kines, IL-1b, IL-6 and IL-8, are already present in mater-
nal serum in early pregnancy but undergo little
subsequent variation until term. At labor onset, IL-1b ris-
es to a sudden short-lasting peak, falling back to preg-
nant and non-pregnant levels on postpartum day one.
IL-6 and IL-8 undergo longer-lasting changes, and are
still not back to antenatal levels by postpartum day three.
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Table 3 IL-1b, IL-6 and IL-8 levels (mean"se) prelabor, during labor, at delivery, and on postpartum days one, two & three (ns38).
log IL-1b log IL-6 log IL-8
Prelabor 0.352"0.030 0.539"0.031 1.134"0.027
During labor 0.545"0.079* 1.063"0.109† 1.374"0.096*
Delivery 0.497"0.070 1.558"0.094† 1.435"0.087‡
Postpartum
Day 1 0.371"0.017 1.190"0.078† 1.235"0.030*
Day 2 0.342"0.013 0.999"0.049† 1.202"0.023
Day 3 0.330"0.010 0.881"0.045† 1.274"0.018§
Versus prelabor: *P-0.05; † P-0.0001; ‡ P-0.005; § P-0.0005 (paired t-test)
Figure 3 Log IL-6 and IL-8 concentrations (mean"se) before (A) and during labor (B), at delivery (C) and 1, 2 and 3 days postpartum
(D–F) in women with (ns8) and without systemic infection.
a) IL-6: *P-0.0001 infection versus no infection at interval B; † P-0.005 at C; and ‡ P-0.05 at E.
b) IL-8: *P-0.005 infection versus no infection at interval C; † P-0.01 at B.
The massive increase in IL-6 at delivery and in the early
puerperium in non-elective cesarean section is unrelated
to either heavy infection, postpartum hemorrhage or
postpartum anemia.
Previous studies on antenatal maternal serum levels
have been cross-sectional, have performed one meas-
urement per trimester, or were limited to one selected IL
w2, 16, 26x. Most have looked at delivery, and at preterm
rather than term labor w1, 17x. Our concern was to meas-
ure all three cytokines longitudinally from early pregnancy
through the early postpartum period.
High cytokine levels in mid and late pregnancy have
usually been attributed to (ascending and intrauterine)
infection w23, 24x. More recent studies suggest that infec-
tion is irrelevant, and that labor resembles an inflamma-
tory process. A study of 28 normal pregnancies and
deliveries, which measured IL-6 in each trimester and at
delivery, found that the only significant increase occurred
at delivery; however, women with a history of recurrent
spontaneous abortion had a higher percentage of detect-
able antenatal IL-6 levels w16x. Similarly, the only previous
longitudinal study (to our knowledge) of maternal serum
IL-6 levels in pregnancy, by Vassiliadis et al. w28x, found
no changes in time course.
IL-8 has been proposed as the final common step in
prostaglandin and antiprogestagen action in parturition
w12x. However, two studies have failed to find significant
changes in peripheral plasma IL-8 levels during pregnan-
cy or at labor onset w3, 15x. We also failed to provide any
indication of a controlling role being played by IL-8 in this
study.
High levels of IL-1b should parallel high levels of
induced cytokines such as IL-8 during vaginal infections
w7x. In vaginal fluid from non-pregnant women with bac-
terial vaginosis (BV), Cauci et al. w4x showed a 20-fold
increase in IL-1b levels, with no change in either IL-8 or
neutrophils; they concluded that virulence factors are
produced in BV that inhibit IL-8 more than they do IL-1b.
We could not confirm these results in peripheral serum
during pregnancy or peripartum. Yudin et al. w29x found
a significant decrease in cervical IL-1b, IL-6 and IL-8 in
pregnant women after oral or vaginal treatment of BV. In
our study, IL-6 values were not increased in women with
BV or Candida infection during the infection or the seven-
day treatment period either during pregnancy or peripar-
tum. The increase of IL-6 and IL-8 in preterm w8, 19x and
term labor w3x is still controversial w1x. We recently report-
ed an increase of IL-6 and IL-8 during normal term labor
w10x. In our present study, all three cytokines were
increased at normal term delivery. Non-elective cesarean
section was associated with higher IL-6 levels than spon-
taneous vaginal delivery. Similar maternal cytokine levels
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Figure 4 Log IL-1b and IL-6 concentrations (mean"se) before (A) and during labor (B), at delivery (C) and 1, 2 and 3 days postpartum
(D–F) in women with blood loss )500 ml (ns6) and -500 ml.
a) IL-1b: *P-0.01)500 ml versus -500 ml at interval B; † P-0.05 at interval D.
b) IL-6: *P-0.05)500 ml versus -500 ml at intervals D and E.
Figure 5 Log IL-8 concentrations (mean"se) before (A) and
during labor (B), at delivery (C) and 1, 2 and 3 days postpartum
(D–F) in patients with (ns9) and without postpartum anemia.
P-0.005 anemia versus no anemia at interval C; † P-0.05 at
interval D.
have been found in mothers with fetuses affected by
microbial invasion w3x. However, we found higher levels
for all three cytokines in mothers with and without sys-
temic infections, including chorioamnionitis.
Our findings support the concept that IL-1b, IL-6 and
IL-8 are involved in the maintenance of human pregnan-
cy. They show that increased cytokine levels are a func-
tion of labor, and are independent of inflammatory factors
such as blood loss, anemia and heavy infection. The role
of IL-1b seems to be limited to parturition; it may be the
initiating cytokine. IL-8 increases early during labor, pos-
sibly as a function of tissue stretching w18x and
membrane rupture w10x. Of all the cytokines, IL-6 showed
the highest (3-fold) and most prolonged increase. Pro-
longed exercise is a documented trigger of leukocytosis
and monocytosis – both cell types are major sources of
IL-6 production w20x; IL-6 increase is also related to
strength of contractions and duration of labor w2, 10x.
Higher IL-6 levels in non-elective cesarean section com-
pared to spontaneous vaginal delivery may be due to tis-
sue injury and its repair over several days rather than to
the onset or maintenance of labor.
A limitation of our study was the 46% decrease in our
recruitment population, to a total of 38 in the final anal-
ysis. These numbers are too small to show statistical dif-
ferences between women with and without local vaginal
infection and/ or urinary tract infection during pregnancy.
The influence of these antenatal factors therefore
requires testing in a larger study. As for the puerperium,
our results show that cytokine increase around sponta-
neous onset delivery is independent of systemic infec-
tion, postpartum hemorrhage and anemia. We assume
that tissue injury accounts for the higher levels found in
non-elective cesarean section compared to vaginal deliv-
ery. However, we could not correlate labor duration with
cytokine concentrations because of external factors (e.g.
parity, ethnicity) resulting in subgroups too small for sta-
tistical analysis. Further studies of larger numbers using
the same sampling schedule could incorporate other
potential determinants such as the effect of elective
cesarean section, which we believe to be low. At present,
our data provide further information on biochemical and
cell-mediated changes in labor and peripartum, which
could serve as provisional reference values to differenti-
ate normal from abnormal events during delivery and the
early puerperium.
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